Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Retinal Consultants of Arizona
With
Allergan
The objective of this study is to assess the safety and efficacy of the OZURDEX® intraocular implant in patients with diabetes mellitus, who develop macular edema after cataract surgery
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient has diagnosis of Diabetes Mellitus, Type I or II.
Patient has experienced the development of macular edema following cataract surgery in at least one eye.
Patient has had cataract surgery within 90 days prior to the screening visit.
You may not be if
Patient has other significant ocular disease in study eye, including glaucoma.
Patient has any active infection in the study eye.
